Insulin Glargine vs Tildrakizumab

## Insulin Glargine vs Tildrakizumab: Overview

This comparison examines the pharmacological differences between **Insulin Glargine** and **Tildrakizumab**.

## Mechanism of Action

**Insulin Glargine**: Long-acting insulin analogue that binds insulin receptors.

## Pharmacokinetics

**Half-life**: Insulin Glargine — 12-24 hours; Tildrakizumab — N/A.

## Chemical Properties

**Type**: Insulin Glargine — Protein; Tildrakizumab — Antibody.